Skip to Content

Regent Pacific Group Ltd RPGLF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Regent Pacific Group Ltd is an investment holding company. It has investments in the healthcare and life sciences sectors. The company runs through two segments: Biopharma, and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. Geographically, it derives a majority of revenue from Hong Kong and also has a presence in China, Europe, and Taiwan.

Contact
5 Queen's Road Central, 8th Floor, Henley Building
Hong Kong, Cayman Islands
T +852 25146111
Sector Financial Services
Industry Asset Management
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 19